CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −6,009 | $25.68 | $154K | 674,242 |
| 2025-12-31 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −33,028 | $25.84 | $853K | 255,205 |
| 2025-12-11 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −459 | $25.50 | $12K | 46,983 |
| 2025-12-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −479 | $24.55 | $12K | 47,442 |
| 2025-12-04 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −7,977 | $24.55 | $196K | 288,233 |
| 2025-12-04 | Swartz Allison EVP, GC | Shares withheld for taxes 10b5-1 | −408 | $24.55 | $10K | 73,249 |
| 2025-12-04 | Swartz Allison EVP, GC | Sale 10b5-1 | −530 | $24.59 | $13K | 72,719 |
| 2025-12-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes 10b5-1 | −224 | $25.27 | $6K | 48,134 |
| 2025-12-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −213 | $25.50 | $5K | 47,921 |
| 2025-12-02 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −448 | $25.27 | $11K | 296,210 |
| 2025-11-28 | Swartz Allison EVP, GC | Shares withheld for taxes 10b5-1 | −1,352 | $26.70 | $36K | 76,055 |
| 2025-11-28 | Swartz Allison EVP, GC | Sale 10b5-1 | −2,398 | $26.87 | $64K | 73,657 |
| 2025-11-18 | Payson Norman Director | Gift | −50,265 | 6,689 | ||
| 2025-11-17 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −21,303 | $25.50 | $543K | 48,358 |
| 2025-11-14 | Payson Norman Director | Exercise or conversion | +36,224 | $1.45 | $53K | 56,954 |
| 2025-11-14 | Payson Norman Director | Exercise or conversion · Stock Option (Right to Buy) | −36,224 | 0 | ||
| 2025-11-13 | Anevski Peter CHIEF EXECUTIVE OFFICER | Purchase | +79,500 | $24.29 | $1.9M | 680,251 |
| 2025-11-10 | Schlanger David J Executive Chairman | Grant or award | +41,500 | 261,919 | ||
| 2025-11-10 | Schlanger David J Executive Chairman | Shares withheld for taxes | −21,286 | $22.37 | $476K | 240,633 |
| 2025-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Grant or award | +125,000 | 664,564 |
Page 7 of 51 · 1,002 trades